| Home | Organizers | Proceedings Editors | Proceedings Contributors | Search | | ||
|
|
|||
|
||||
|
|
||||
| Title: | THE DIFFERENCES IN THE BULGARIAN GENERAL PRACTITIONERS' AND CARDIOLOGISTS' APPROACH TO THE SUPRAVENTRICULAR TACHYCARDIAS MANAGEMENT | |
| DOI No: | 10.1142/9789812702234_0088 | |
| Source: | ADVANCES IN ELECTROCARDIOLOGY 2004 (pp 336-339) | |
| Author(s): | BORISLAV GEORGIEV
National Heart Hospital, Sofia, Bulgaria NINA GOTCHEVA National Heart Hospital, Sofia, Bulgaria ILIA TOMOV National Heart Hospital, Sofia, Bulgaria |
|
| Abstract: | The aim of this study was to analyze the general practitioners' (GPs), outpatient cardiologists' and inhospital specialists' management approach to the patients with supraventricular tachycardias (SVTs).We evaluated the approach of 926 GPs, 184 outpatient cardiologists and 216 inhospital specialists.1% of the GPs, 1.4% of the outpatient cardiologists and 2% of the inhospital specialists did not treat SVTs if there were no symptoms. 34% of the GPs' pts with SVTs could be consulted by cardiologist and 14% of the outpatient cardiologists' pts with SVTs - by inhospital specialists.The rest of the pts were treated as follows:1) The GPs' preference (drug treated pts=64%) Quinidine - 2%, Propafenone - 7%, Lidocaine – below 1%, beta-blockers -1 5%, calcium-channel blockers from non-dihydropyridine group (NDHP-CCB) - 15%, Digoxine - 7%, Amiodarone - 9%, Sotalol - 3%;2) The outpatient cardiologists' preference (drug treated pts = 84%) Quinidine - 1%, Propafenone - 16%, Lidocaine – below 1%, beta-blockers - 20%, NDHP-CCB - 20%, Digoxine - 6%, Amiodarone - 12%, Sotalol - 6%;3) The inhospital specialists' preference (drug treated pts = 69%) Quinidine - 1%, Propafenone - 15%, Lidocaine – below 1%, beta-blockers - 19%, NDHP-CCB - 22%, Digoxin – 8, Amiodarone - 11%, Sotalol - 2%.Conclusions: The pts with SVTs were seen first by GPs who had to choose the treatment approach. Relatively high percentage of GPs' pts was consulted by specialists. More than 50% of pts with SVTs treatment were out-patient. Beta-blockers were frequently used in SVTs treatment, followed by calcium channel blockers and Propafenone, and we observed the use of Amiodarone in about 12% in the physicians' preference. | |
| Full Text: | View full text in PDF format (172KB) | |
| TOC: | Back to Table of Contents | |
|
||